China Olaparib advance intermediate Factory

Our staff are generally while in the spirit of "continuous improvement and excellence", and while using the excellent high quality merchandise, favorable value and great after-sales services, we try to gain each customer's have faith in for Olaparib advance intermediate,CAS NO 119-67-5,119-67-5,Olaparib intermediate,2-Carboxybenzaldehyde, Adhering for the enterprise philosophy of 'customer initial, forge ahead', we sincerely welcome consumers from in the home and abroad to cooperate with us.
Olaparib advance intermediate, Our Company has specialist engineers and technical staff to answer your questions about maintenance problems, some common failure. Our product quality assurance, price concessions, any questions about the products, You should feel free to contact us.

Hot Products

  • 2-(tert-Butoxycarbonyl)-2,7-diazaspiro[3.5]nonane

    2-(tert-Butoxycarbonyl)-2,7-diazaspiro[3.5]nonane

    Product Name:2-(tert-Butoxycarbonyl)-2,7-diazaspiro[3.5]nonane
    Molecular Formula:C12H22N2O2
    Molecular Weight:226.32
    CAS Registry Number:236406-55-6
  • Dipyridamole

    Dipyridamole

    Product Name:Dipyridamole
    Molecular Formula:C24H40N8O4
    Molecular Weight;504.63
    CAS Registry Number;58-32-2
  • Esaxerenone

    Esaxerenone

    Product Name:Esaxerenone
    Molecular Formula:C22H21F3N2O4S
    Molecular Weight;466.48
    CAS Registry Number;1632006-28-0
  • FMOC-L-Leucine

    FMOC-L-Leucine

    Product Name:FMOC-L-Leucine
    Molecular Formula:C21H23NO4
    Molecular Weight:353.41
    CAS Registry Number:35661-60-0
  • Cenobamate

    Cenobamate

    Product Name:Cenobamate
    Molecular Formula:C10H10ClN5O2
    Molecular Weight;267.67
    CAS Registry Number;913088-80-9
  • 2'-Chloroacetophenone

    2'-Chloroacetophenone

    Product Name:2'-Chloroacetophenone
    Molecular Formula:C8H7ClO
    Molecular Weight:154.59
    CAS Registry Number:2142-68-9

Send Inquiry

X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept